NCT05203692 A Study of a Single Ascending Dose Study of DS-7011a in Healthy Subjects Status COMPLETED Phase PHASE1
NCT05179018 Clinical and Diagnostic Value of Ribosomal p2 Autoantibodies in Systemic Lupus Erythematosus Status UNKNOWN Phase N/A
NCT05162586 The WILLOW Study With M5049 in SLE and CLE (SCLE and/or DLE) (WILLOW) Status COMPLETED Phase PHASE2
NCT05157334 The Effect of Deep Breathing and Transcutaneus Electrical Nerve Stimulation on Heart Rate Variability Status UNKNOWN Phase NA
NCT05155345 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneously Administered Mosunetuzumab to Participants With Systemic Lupus Erythematosus Status COMPLETED Phase PHASE1
NCT05146414 Clonal Hematopoiesis of Indeterminate Potential and Accelerated Atherosclerosis in Systemic Lupus Erythematosus Status COMPLETED Phase N/A
NCT05132621 The Genital Tract Microflora in Women With Systemic Lupus Erythematosus (SLE) and Immunoglobulin A (IgA) Nephropathy. Status UNKNOWN Phase N/A
NCT05123586 A IMMA Master Protocol: A Study of LY3361237 in Participants With at Least Moderately Active Systemic Lupus Erythematosus Status TERMINATED Phase PHASE2
NCT05116163 Breaking Implicit Bias Habits: An Individuation Pilot Study In Rheumatology Status COMPLETED Phase NA
NCT05115370 Vaccination Perception in Inflammatory Conditions - Flu, Pneumonia and COVID-19 Status COMPLETED Phase N/A
NCT05105217 Evaluation of Slit2 in Systemic Lupus Erythematosus and Systemic Sclerosis Patients Status UNKNOWN Phase N/A
NCT05090189 Exercise and Nutrition Recommendations for Patients Using Glucocorticoids (ENRG) Status UNKNOWN Phase NA
NCT05057481 Reappraisal of the Therapies of Refractory Autoimmune Hemolytic Anemia in Systemic Lupus Erythematosus Status UNKNOWN Phase PHASE3
NCT05045417 IL17 in Systemic Lupus Erythematosus Patients: Association With Disease Activity and Organ Damage Status UNKNOWN Phase N/A
NCT05039840 Efficacy and Safety of Frexalimab (SAR441344) in the Treatment of Systemic Lupus Erythematosus Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05030779 A Study of CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory Systemic Lupus Erythematosus Status UNKNOWN Phase EARLY_PHASE1
NCT05029336 Autologous Stem Cell Transplant (ASCT) for Autoimmune Diseases Status RECRUITING Phase PHASE2
NCT05001737 Evaluate Efficacy, Safety and Tolerability, PK and PD of Emapalumab in Children and Adults With MAS in Still's or SLE Status COMPLETED Phase PHASE3